Live Quote · NASDAQMGNXHealthcare· Biotechnology

MacroGenics, Inc.

$1.96▼ 1.01%($-0.02)
MKT CAP $125.26MNEXT EARNINGS Mar 8, 2027
50%
Bullish
TickerSpark Score
43/100
▌ Weak
70
Valuation
20
Profitability
25
Growth
68
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a MGNX research report →

Analyst Price Target
$6.00+206.1% vs. today

Range $6 – $6

Analyst RatingBuy
12 Buy9 Hold1 Sell

Price Chart

+44.16% · this period
$4.86$3.10$1.33Nov 20May 26Nov 20
52-Week Range17% of range
Low
$1.32
Current
$1.96
High
$5.08